Clinical Trial Update: TOward the Lowest Effective DOse of Abatacept or Tocilizumab [Phase 4]

View source ↗

Summary

Phase 4 trial updating on achieving the lowest effective dose of abatacept or tocilizumab for rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Abatacept (abatacept)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED